Literature DB >> 18097710

Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients.

Servet Akar1, Gercek Can, Omer Binicier, Kenan Aksu, Baris Akinci, Dilek Solmaz, Merih Birlik, Gökhan Keser, Nurullah Akkoc, Fatos Onen.   

Abstract

The aims of the study were to assess the health-related quality of life (QOL) in patients with Takayasu's arteritis (TA) by two different generic QOL instruments and to compare the results with those patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and healthy controls (HC). A cross-sectional study was performed in 51 patients with TA (41 women; mean age 38.4 +/- 13.5), 43 RA (36 women; 55.2 +/- 9.6), 31 AS (12 women; 41.2 +/- 13.1), and 75 HC (53 women; 38.8 +/- 10.9). Quality of life was assessed by using Short-Form 36 (SF-36) and Nottingham Health Profile (NHP). Separate dimensions of SF-36 and NHP and physical and mental summary scores of SF-36 as well were compared between patients and control groups. Physical and mental health summary scores and all SF-36 subscales, except for social functioning, were significantly lower in patients with TA than healthy controls. No significant differences between TA, RA, and AS patients were found in all SF-36 subscales and summary scores. NHP scores for energy level, pain, emotional reactions, and physical mobility were significantly higher in TA patients than controls. All NHP subscales, except for pain, were comparable in patients with TA, RA, and AS. Pain score was worse in RA patients. The NHP scores for sleep and social isolation were not different between patients and controls. Many aspects of QOL in patients with TA are significantly impaired in comparison with local healthy controls and similar to those in patients with RA and AS.

Entities:  

Mesh:

Year:  2007        PMID: 18097710     DOI: 10.1007/s10067-007-0813-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  Reliability and construct validity of the SF-36 in Turkish cancer patients.

Authors:  Rukiye Pinar
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

3.  Angiographic findings of Takayasu arteritis: new classification.

Authors:  A Hata; M Noda; R Moriwaki; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

4.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

6.  Natural history of aortoarteritis (Takayasu's disease).

Authors:  R Subramanyan; J Joy; K G Balakrishnan
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis.

Authors:  Maria Koutantji; Emma Harrold; Suzanne E Lane; Shirley Pearce; Richard A Watts; David G I Scott
Journal:  Arthritis Rheum       Date:  2003-12-15

9.  A generic health status instrument in the assessment of rheumatoid arthritis.

Authors:  R Fitzpatrick; S Ziebland; C Jenkinson; A Mowat; A Mowat
Journal:  Br J Rheumatol       Date:  1992-02

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  16 in total

1.  The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission.

Authors:  Delesha M Carpenter; Jessica A Kadis; Robert F Devellis; Susan L Hogan; Joanne M Jordan
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

2.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 3.  Advances in the diagnosis, assessment and outcome of Takayasu's arteritis.

Authors:  Fatma Alibaz-Oner; Sibel Zehra Aydin; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

4.  Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study.

Authors:  Alexandre Moura Dos Santos; Rafael Giovani Misse; Isabela Bruna Pires Borges; Bruno Gualano; Alexandre Wagner Silva de Souza; Liliam Takayama; Rosa Maria R Pereira; Samuel Katsuyuki Shinjo
Journal:  Adv Rheumatol       Date:  2021-01-08

Review 5.  Recent advances in Takayasu's arteritis.

Authors:  Fatma Alibaz-Öner; Sibel Zehra Aydın; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2015-03-01

Review 6.  Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

Authors:  Sibel Zehra Aydin; Haner Direskeneli; Antoine Sreih; Fatma Alibaz-Oner; Ahmet Gul; Sevil Kamali; Gulen Hatemi; Tanaz Kermani; Sarah L Mackie; Alfred Mahr; Alexa Meara; Nataliya Milman; Heidi Nugent; Joanna Robson; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2015-06-15       Impact factor: 4.666

Review 7.  Assessment of disease activity and progression in Takayasu's arteritis.

Authors:  Haner Direskeneli; Sibel Z Aydin; Peter A Merkel
Journal:  Clin Exp Rheumatol       Date:  2011-05-11       Impact factor: 4.473

8.  Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Authors:  Antoine G Sreih; Fatma Alibaz-Oner; Tanaz A Kermani; Sibel Z Aydin; Peter F Cronholm; Trocon Davis; Ebony Easley; Ahmet Gul; Alfred Mahr; Carol A McAlear; Nataliya Milman; Joanna C Robson; Gunnar Tomasson; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

9.  Takayasu's arteritis associated with Crohn's disease.

Authors:  You-shi Liu; You-hong Fang; Ling-xiang Ruan; You-ming Li; Lin Li; Ling-ling Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2009-08       Impact factor: 3.066

10.  Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients.

Authors:  Serpil Muge Deger; Mehmet Akif Ozturk; Mehmet D Demirag; Selcuk Aslan; Berna Goker; Seminur Haznedaroglu; A Mesut Onat
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.